Clinical Trial Update: Pilot Trial for Treatment of Recurrent Glioblastoma [EARLY_Phase 1]

View source ↗

Summary

A pilot early-phase 1 trial evaluating a treatment for recurrent glioblastoma is currently recruiting, sponsored by AHS Cancer Control Alberta.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Snippet

Sponsor: AHS Cancer Control Alberta | Conditions: Glioblastoma, Recurrent Disease | EARLY_Phase 1 | Status: RECRUITING